Tucidinostat
Relapsed Adult AML
The First Affiliated Hospital of Xiamen UniversitySmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 81/ 100
Competitive context
13 Active assets in the Relapsed Adult AML cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Azacitidine Institute of Hematology & Blood Diseases Hospital, China | Phase 2 | B |
Venetoclax Medical College of Wisconsin | Phase 2 | B |
FILGRASTIM Medical College of Wisconsin | Phase 2 | B |
Cytosin-Arabinosid Medical College of Wisconsin | Phase 2 | B |
5-azacytidine The First Affiliated Hospital of Soochow University | Phase 2 | CCC |
View all 19 →
Same molecule, other indications
Tucidinostat is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →